Edap TMS SA (EDAP)
7.14
-0.20
(-2.72%)
USD |
NASDAQ |
May 03, 16:00
7.28
+0.14
(+1.96%)
After-Hours: 20:00
Edap TMS 1 Year Total Returns (Daily): -37.64% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -37.64% |
May 02, 2024 | -34.11% |
May 01, 2024 | -35.98% |
April 30, 2024 | -34.60% |
April 29, 2024 | -32.56% |
April 26, 2024 | -32.22% |
April 25, 2024 | -32.11% |
April 24, 2024 | -36.25% |
April 23, 2024 | -34.05% |
April 22, 2024 | -33.49% |
April 19, 2024 | -32.15% |
April 18, 2024 | -32.99% |
April 17, 2024 | -30.57% |
April 16, 2024 | -31.52% |
April 15, 2024 | -30.30% |
April 12, 2024 | -28.25% |
April 11, 2024 | -26.45% |
April 10, 2024 | -21.24% |
April 09, 2024 | -20.19% |
April 08, 2024 | -21.69% |
April 05, 2024 | -22.01% |
April 04, 2024 | -27.07% |
April 03, 2024 | -29.87% |
April 02, 2024 | -31.62% |
April 01, 2024 | -31.71% |
Date | Value |
---|---|
March 28, 2024 | -34.49% |
March 27, 2024 | -37.22% |
March 26, 2024 | -35.05% |
March 25, 2024 | -34.16% |
March 22, 2024 | -33.11% |
March 21, 2024 | -34.11% |
March 20, 2024 | -30.19% |
March 19, 2024 | -30.29% |
March 18, 2024 | -32.96% |
March 15, 2024 | -33.04% |
March 14, 2024 | -37.17% |
March 13, 2024 | -35.88% |
March 12, 2024 | -37.74% |
March 11, 2024 | -38.16% |
March 08, 2024 | -39.86% |
March 07, 2024 | -39.35% |
March 06, 2024 | -38.52% |
March 05, 2024 | -37.69% |
March 04, 2024 | -39.13% |
March 01, 2024 | -44.72% |
February 29, 2024 | -46.30% |
February 28, 2024 | -51.06% |
February 27, 2024 | -50.46% |
February 26, 2024 | -51.20% |
February 23, 2024 | -49.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-59.26%
Minimum
Apr 16 2020
370.9%
Maximum
Mar 18 2021
34.60%
Average
23.58%
Median
Oct 20 2021
1 Year Total Returns (Daily) Benchmarks
Biophytis SA | -94.31% |
DBV Technologies SA | -57.25% |
Cellectis SA | 60.75% |
Genfit SA | -14.33% |
Biodexa Pharmaceuticals Plc | -93.25% |